UBS Maintains Sell on Aveanna Healthcare Hldgs, Raises Price Target to $2.8
Portfolio Pulse from Benzinga Newsdesk
UBS analyst A.J. Rice maintains a Sell rating on Aveanna Healthcare Holdings (NASDAQ:AVAH) but raises the price target from $1.7 to $2.8.
August 09, 2024 | 2:22 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
UBS analyst A.J. Rice maintains a Sell rating on Aveanna Healthcare Holdings (NASDAQ:AVAH) but raises the price target from $1.7 to $2.8.
The Sell rating suggests a negative outlook, but the raised price target indicates some positive reassessment of the company's value. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100